Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease

Program Overview

The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors underscore the importance of specialty referral and shared decision making in the successful management of NTM-LD, as Dr. Anne O’Donnell and her patient, Brinkley, exemplify.

Credit Expired

Target Audience

The target audience for this activity is US-based pulmonologist and infectious disease specialists.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the current epidemiologic trends and burden posed by nontuberculous mycobacteria lung disease (NTM-LD) and its treatment
Institute best practices for NTM-LD management with available treatment options, including proactive monitoring for adverse events and adherence to existing and new treatments
Effectively incorporate shared decision making into management of patients with NTM-LD

Activity Faculty

Anne E. O'Donnell, MD

Professor, Medicine
Nehemiah and Naomi Cohen Chair in Pulmonary Disease Research
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Georgetown University Hospital
Washington, DC

Featured RMEI CE Activities – Earn CE Credit(s)

A Non-CME Educational Program during the 2025 AAAAI/WAO Joint Congress: Expert Panel Discussion Featuring a Patient

A Violent Graft in a Vulnerable Host: The Future of aGvHD Management: A Care Team Forum®

1.5 CE Credit(s)

Rapid Recognition and Management of T-Cell Therapy-Related Toxicities in B-Cell Lymphomas: Crucial Updates for the Emergency Department

1.0 CE Credit(s)

Privacy | Terms of Use